CRISPR-Cas9 for cancer therapy: Opportunities and challenges

Minjiang Chen, Aiwu Mao, Min Xu, Qiaoyou Weng, Jianting Mao, Jiansong Ji

View at source ↗Review272 citations
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.

Record

Archive ID
doi:10.1016/j.canlet.2019.01.017
Published
Jan 24, 2019
Venue
Cancer Letters
DOI
10.1016/j.canlet.2019.01.017
PubMed
30684591
Categories
CRISPR and Genetic Engineering
Provenance
openalex

Topics